← Back to Clinical Trials
Recruiting NCT04010214

A Registered Cohort Study on Cerebellar Ataxia in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Cerebellar Ataxia
Sponsor Ning Wang, MD., PhD.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,500
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2019-07-01
Completion 2039-12
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese patients with cerebellar ataxia.

Eligibility Criteria

Inclusion Criteria: * Patients with cerebellar ataxia based on the diagnoses of tow neurologists * Relatives of patients with cerebellar ataxia * Unrelated healthy controls * Participants or legal guardian(s) willing and able to complete the informed consent process Exclusion Criteria: * Participants are unable to comply with trial procedures and visit schedule

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE CEREBELLAR ATAXIA TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}